How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

The potential health and economic value of a vaccine for coronavirus disease (COVID-19) is self-evident given nearly 2 million deaths, “collateral” loss of life as other conditions go untreated, and massive economic damage. Results from the first licensed products are very encouraging; however, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Towse, Adrian, Chalkidou, Kalipso, Firth, Isobel, Kettler, Hannah, Silverman, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:
Themed Section: COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892302/
https://www.ncbi.nlm.nih.gov/pubmed/33933230
http://dx.doi.org/10.1016/j.jval.2020.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892302/
https://www.ncbi.nlm.nih.gov/pubmed/33933230
http://dx.doi.org/10.1016/j.jval.2020.12.008

Ejemplares similares